Renal Cell Cancer : News
Print
EmailHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
|
AVEO Pharmaceuticals, Inc., a biotechnology company leveraging breakthrough discoveries in cancer biology to discover, develop and commercialize targeted oncology therapies, today announced that it has ...
|
|
... lay comatose in hospital wards where hopeless families gathered awaiting their inevitable deaths. This was not cancer before chemotherapy, or tuberculosis before antibiotics. This was Type I diabetes before insulin. That was prior to 1922 when ...
|
|
... small, incidentally detected tumors. The organs had come from 38 patients who had a kidney removed for presumed renal cell cancer and from 3 deceased donors. After surgery to remove the tumor, all the kidneys were successfully transplanted. Most of ...
|
|
Hoping to repeat its Phase II success, privately held NovaRx Corp. launched a pivotal study of therapeutic vaccine Lucanix in non-small-cell lung cancer patients under a special protocol assessment approved ...
|
|
... a time for quiet introspection and celebration. With the event's first lap and a complimentary dinner dedicated to cancer survivors, individuals like Martin are recognized annually for their courageous battle. "Last year I was still trying to deal ...
|
|
... diseases including macular degeneration, rheumatoid arthritis, transplant rejection and cardiovascular and renal ischemia-reperfusion injury. "This agreement marks an important milestone in our MASP-2 program, and ensures that Omeros can access ...
|
|
Consuming large amounts of acrylamide, a chemical commonly found in French fries, cakes, snacks and even coffee, appears to raise the risk of kidney cancer, especially in smokers, Dutch researchers report.
|
|
... (NICE) made his comments to the Observer newspaper. NICE has recently been criticised for failing to approve kidney cancer drugs. Double-digit growth It advises the NHS in England and Wales on which drugs to buy. Sir Michael said: "We are told we ...
|
|
... caused by membranous nephropathy in some patients, according to a new study. The drug, originally developed as a cancer treatment for people with B cell lymphoma, selectively depletes B lymphocytes, cells that produce kidney-damaging autoantibodies. ...
|
|
... samples. Examples of commercial diagnostic and prognostic applications of the patented technology include circulating cell screening and cytopathology slide analysis, among others. Circulating tumor cells (CTCs) and/or circulating epithelial cells ...
|
|
A cancer diagnosis is horrific for any patient. But when adolescents and young adults , patients ages 15 to 39, are diagnosed, they face higher mortality rates and a myriad of psycho-social issues that ...
|
|
This herbal extract has proven effective in healing infections. Research in America has shown that Astragali increases the number of T-cells in cancer patients to normal levels.
|
|
Main Category: Urology / Nephrology Also Included In: Cancer / Oncology Article Date: 10 Aug 2008 UroToday.com - Metastatic renal cell carcinoma was once considered to be a disease without significant ...
|
|
... so because he is one of the lucky few to have won a funding battle for the drug Sutent that keeps his advanced kidney cancer at bay. Yesterday,THU the shocked farmer took time out from preparing his cattle for market to blast a decision that will ...
|
|
... support continuation of the studies. In the Phase 3 program, Hematide is being evaluated to treat anemia in chronic renal failure patients on dialysis and not on dialysis. "These are very important reviews by the DMC and we are pleased that the ...
|
|
... drug candidates and an extensive set of back-up compounds targeting a kinase critical for growth and survival of cancer cells. Bayer Schering Pharma will assume full development and commercialization rights of the program. The company is making this ...
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.